GLUE NASDAQ
Monte Rosa Therapeutics, Inc.
1W: +1.1%
1M: -10.0%
3M: -0.5%
YTD: +23.3%
1Y: +353.9%
3Y: +237.8%
$18.81
-0.07 (-0.37%)
Weekly Expected Move ±7.0%
$16
$17
$18
$19
$21
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026209
Institutions Holding
+32 vs prior
77.8%
Ownership
+2.12%
49
New
68
Increased
80
Reduced
45
Closed
👔 Insider Trades
23 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-14 | Warmuth Markus | officer: president & ceo | S-Sale | 8,000 | $17.64 | $141K | Filing |
| 2026-04-09 | Nickson Philip | officer: chief business & legal officer | S-Sale | 5,845 | $17.69 | $103K | Filing |
| 2026-03-04 | Dunn Edmund | officer: principal accounting officer | S-Sale | 139 | $17.96 | $2K | Filing |
| 2026-03-02 | Dunn Edmund | officer: principal accounting officer | S-Sale | 536 | $17.50 | $9K | Filing |
| 2026-03-02 | Warmuth Markus | officer: president & ceo | S-Sale | 5,466 | $17.92 | $98K | Filing |
| 2026-02-27 | Dunn Edmund | officer: principal accounting officer | S-Sale | 25,164 | $18.10 | $456K | Filing |
| 2026-02-23 | Janku Filip | officer: chief medical officer | S-Sale | 9,189 | $19.50 | $179K | Filing |
| 2026-01-07 | Warmuth Markus | officer: president & ceo | S-Sale | 3,707 | $23.24 | $86K | Filing |
| 2026-01-07 | Warmuth Markus | officer: president & ceo | S-Sale | 1,450 | $23.88 | $35K | Filing |
| 2026-01-07 | Warmuth Markus | officer: president & ceo | S-Sale | 309 | $24.57 | $8K | Filing |
| 2026-01-05 | Champoux Jennifer | officer: chief operating officer | S-Sale | 2,629 | $15.17 | $40K | Filing |
| 2026-01-05 | Dunn Edmund | officer: principal accounting officer | S-Sale | 1,039 | $15.17 | $16K | Filing |
| 2026-01-05 | Janku Filip | officer: chief medical officer | S-Sale | 3,155 | $15.17 | $48K | Filing |
| 2026-01-05 | Townson Sharon | officer: chief scientific officer | S-Sale | 3,155 | $15.17 | $48K | Filing |
| 2026-01-05 | Warmuth Markus | officer: president & ceo | S-Sale | 10,135 | $15.17 | $154K | Filing |
| 2026-01-05 | Nickson Philip | officer: chief business & legal officer | S-Sale | 3,155 | $15.17 | $48K | Filing |
| 2026-01-02 | Champoux Jennifer | officer: chief operating officer | A-Grant/Award | 35,000 | $— | $0 | Filing |
| 2026-01-02 | Janku Filip | officer: chief medical officer | A-Grant/Award | 31,000 | $— | $0 | Filing |
| 2026-01-02 | Townson Sharon | officer: chief scientific officer | A-Grant/Award | 35,000 | $— | $0 | Filing |
| 2026-01-02 | Warmuth Markus | officer: president & ceo | A-Grant/Award | 90,000 | $— | $0 | Filing |
| 2026-01-02 | Nickson Philip | officer: chief business & legal officer | A-Grant/Award | 28,000 | $— | $0 | Filing |
| 2025-06-03 | Dunn Edmund | officer: principal accounting officer | S-Sale | 2,062 | $4.45 | $9K | Filing |
| 2025-03-24 | Leo Chandra P. | director | P-Purchase | 10,000 | $5.84 | $58K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 7,692,298 | $127M | — | 2026-03-31 | Filing |
| BlackRock, Inc. | 5,637,684 | $93M | +1,456,523 | 2026-03-31 | Filing |
| TCG Crossover Management, LLC | 4,622,151 | $76M | — | 2026-03-31 | Filing |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,226,809 | $70M | +866,809 | 2026-03-31 | Filing |
| STATE STREET CORP | 3,353,980 | $55M | +1,246,500 | 2026-03-31 | Filing |
| Versant Venture Management, LLC | 3,180,780 | $52M | -1,201,907 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,100,245 | $51M | +3,100,245 | 2026-03-31 | Filing |
| AMERICAN CENTURY COMPANIES INC | 2,809,647 | $46M | +1,480,028 | 2026-03-31 | Filing |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,002,040 | $33M | +972,974 | 2026-03-31 | Filing |
| Aisling Capital Management LP | 1,555,664 | $26M | +83,333 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,540,812 | $25M | +335,968 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,041,372 | $17M | +473,005 | 2026-03-31 | Filing |
| FMR LLC | 1,024,304 | $17M | -275,792 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,001,527 | $16M | +705,649 | 2026-03-31 | Filing |
| Frazier Life Sciences Management, L.P. | 1,000,000 | $16M | +1,000,000 | 2026-03-31 | Filing |
| NORTHERN TRUST CORP | 826,624 | $14M | +129,590 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 685,926 | $11M | +685,926 | 2026-03-31 | Filing |
| Alphabet Inc. | 684,275 | $11M | -60,673 | 2026-03-31 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 658,483 | $11M | -126,574 | 2026-03-31 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 647,739 | $11M | +340,088 | 2026-03-31 | Filing |